America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...

Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.

BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation ...

Moderna announced the change Wednesday, about a week after revealing that the FDA’s vaccine chief was refusing to review the ...

The Food and Drug Administration has reversed its shocking refusal to consider Moderna’s mRNA flu vaccine for approval.

First mRNA vaccine to be produced in UK approved by regulators - The Moderna Innovation and Technology Centre will make millions of cutting-edge mRNA vaccines ...

It feels counterintuitive that the U.S. Food and Drug Administration would refuse to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology.

After initially rejecting Moderna’s application for review, the FDA will now consider the company’s mRNA flu shot ...

Their worst fears are starting to come true, according to executives and investors involved with companies that develop and sell vaccines and the mRNA technology that is best known for the Covid ...

The FDA will now review Moderna’s seasonal mRNA influenza vaccine application, setting a mid-2026 decision date.

Technology, Innovation, and the Fate of Nations (Princeton University Press, 2025) is somewhat mis-named. Undoubtedly selected by publishers, ...

Federal policies under Robert F. Kennedy Jr. that are hostile to vaccines have “sent a chill through the entire industry,” one scientist said.